PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+42.48%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$118M
AUM Growth
+$118M
(+26%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-30.35%
Top 10 Holdings %
Top 10 Hldgs %
99.23%
Holding
12
New
–
Increased
1
Reduced
4
Closed
–
Top Buys
| 1 |
Cartesian Therapeutics
RNAC
|
$2.76M |
Top Sells
| 1 |
X4 Pharmaceuticals
XFOR
|
$27.1M |
| 2 |
Fate Therapeutics
FATE
|
$6.15M |
| 3 |
Pulmatrix
PULM
|
$4.1M |
| 4 |
Neuronetics
STIM
|
$1.26M |
Sector Composition
| 1 | Healthcare | 59.95% |
| 2 | Communication Services | 35.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cardlytics
CDLX
$54.3M
| $42.5M | 35.95% |
2,552,626
| – | – |
|
|
2
Fate Therapeutics
FATE
$120M
| $25.9M | 21.9% |
1,473,186
-350,000
| -19% | -$6.15M |
|
3
KALA BIO
KALA
$78.8M
| $15.4M | 13% |
1,857,582
| – | – |
|
|
4
Neuronetics
STIM
$220M
| $11.3M | 9.58% |
742,289
-82,476
| -10% | -$1.26M |
|
|
5
Cartesian Therapeutics
RNAC
$261M
| $6.57M | 5.56% |
2,773,479
+1,166,666
| +73% | +$2.76M |
|
|
6
X4 Pharmaceuticals
XFOR
$84.2M
| $5.42M | 4.59% |
311,492
-1,557,465
| -83% | -$27.1M |
|
|
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
| $4.84M | 4.1% |
1,841,924
| – | – |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $3.2M | 2.71% |
2,053,540
| – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $1.16M | 0.98% |
1,968,606
| – | – |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $1.01M | 0.85% |
1,827,992
| – | – |
|
11
Dare Bioscience
DARE
$27.2M
| $457K | 0.39% |
326,243
| – | – |
|
|
12
Pulmatrix
PULM
$18M
| $456K | 0.39% |
359,438
-3,234,943
| -90% | -$4.1M |
|